Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer

Endocrinology and Metabolism Clinics of North America

Volumn 19, Issue 3, 1990, Pages 685-718

  Maxon III, H R ^a   Smith, H S ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; LITHIUM; RADIOACTIVE IODINE; RADIOISOTOPE; THYROXINE;

COMPLICATION; CONTROLLED STUDY; GAMMA IRRADIATION; HUMAN; MAJOR CLINICAL STUDY; METASTASIS; METHODOLOGY; PRIORITY JOURNAL; REVIEW; THYROID MEDULLARY CARCINOMA;

EID: 0025042810     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0889-8529(18)30317-7     Document Type: Review

References (134)

1. Abbatt j.D. Brown W.M.C. Farran H.E.A. Radiation sickness in man following the administration of therapeutic radioiodine: Relationship between latent period, dose- rate and body size Br j Radiol 28 1955 358
2. Abdel-Dayem H.M. Halker K. Sayed M.E. The radioactive wig in iodine-131 whole body imaging Clin Nucl Med 9 1985 454
3. Abe K. Yoneda K. Fujita R. The effects of epinephrine, norepinephrine, and phenylephrine on the types of proteins secreted by rat salivary glands J Dent Res 59 1980 1627
4. Acosta J. Chitkara R. Khan F. Radioactive iodine uptake by a large cell undifferentiated bronchogenic carcinoma Clin Nucl Med 7 1982 368
5. Ahmed S.R. Shalet S.M. Gonadal damage due to radioactive iodine treatment for thyroid carcinoma Postgrad Med J 61 1985 361
6. Aldinger K.A. Samaan N.A. Ibanez M. Anaplastic carcinoma of the thyroid: A review of 84 cases of spindle and giant cell carcinoma of the thyroid Cancer 41 1978 2267
7. Aldrich L.B. Sisson H. Grum C.M. Pulmonary function in thyroid carcinoma metastatic to the lung j Endocrinol Invest 10 1987 111
8. Allweiss P. Braunstein G.D. Katz A. Sialadenitis following 131I therapy for thyroid carcinoma: Concise communication j Nucl Med 25 1984 755
9. Ardito G. Lamberti L. Bigatti P. Comparison of chromosome aberration frequency before and after administration of 131I in two groups of thyroid cancer patients Tumori 73 1987 257
10. Arnstein N.B. Carey j.E. Spaulding S.A. Determination of iodine-131 diagnostic dose for imaging metastatic thyroid cancer J Nucl Med 27 1986 1764
11. Benua R.S. Cicale N.R. Sonenberg M. The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer AjR 87 1962 171
12. Beierwaltes W.H. The treatment of thyroid carcinoma with radioactive iodine Semin Nucl Med 8 1978 79
13. Brachman M.B. Rothman B.J. Ramanna L. False-positive iodine-131 body scan caused by a large renal cyst Clin Nucl Med 13 1988 416
14. Briere j. Philippon B. Absorbed dose to ovaries or uterus during a 131-I-therapeutic of cancer or hyperthyroidism: Comparison between in vivo measurements by TLD and calculations International journal of Applied Radiation and Isotopes 30 1979 643
15. Brincker H. Hansen H.S. Andersen A.P. Induction of leukaemia by 131I treatment of thyroid carcinoma Br j Cancer 28 1973 232
16. Brown A.P. Greening W.P. McCready V.R. Radioiodine treatment of metastatic thyroid carcinoma: The Royal Marsden Hospital experience Br j Radiol 57 1984 323
17. Bubeck B. Kimmig B. Hermann H.J. Die radiojodtherapie des differenzierten schilddrusenkarzinoms Strahlentherapie 160 1984 594
18. Cady B. Rossi R. Silverman M. Further evidence of the validity of risk group definition in differentiated thyroid carcinoma Surgery 98 1985 1171
19. Caplan R.H. Gundersen G.A. Abellera R.M. Uptake of iodine-131 by a Meckel's diverticulum mimicking metastatic thyroid cancer Clin Nucl Med 12 1987 760
20. Carcangiu M.L. Zampi G. Pupi A. Papillary carcinoma of the thyroid: A clinico- pathologic study of 241 cases treated at the University of Florence, Italy Cancer 55 1985 805
21. Castronovo FP J.r. Beh R.A. Veilleux N.M. Dosimetric considerations while attending hospitalized 1-131 therapy patients Journal of Nuclear Medical Technology 10 1982 157
22. Ceccarelli C. Pacini F. Lippi F. An unusual case of a false-positive iodine-131 whole body scan in a patient with papillary thyroid cancer Clin Nucl Med 13 1988 192
23. Cerletty J.M. Listwan W.J. Hypothyroidism due to functioning metastatic thyroid carci noma: Precipitation of thyroid storm with therapeutic radioactive iodine JAMA 242 1979 269
24. Connell J.M.C. Hilditch T.E. Robertson J. Radioprotective action of carbimazole in radioiodine therapy for thyrotoxicosis–influence of the drug on iodine kinetics Eur J Nucl Med 13 1987 358
25. Correns H.J. Buchali K. Donat R. Uberlebenszeiten von patienten mit schilddru- senmalignomen nach radioiodtherapie Radiobiol Radiother (Berl) 25 1984 405
26. Creutzig H. Sialadenitis following iodine-131 therapy for thyroid carcinoma [letter] J Nucl Med 26 1985 817
27. Dansereau R. Dansereau R. A new coated-bead dosage form of sodium iodide 1-131[abstract] J Nucl Med 30 1989 886
28. Datz F.L. Cerebral edema following iodine-131 therapy for thyroid carcinoma metastatic to the brain J Nucl Med 27 1986 637
29. Deeg M. Maier H. Bihl H. Klinisches bild und mögliche Ursachen der funktions- storungen der glandula parotis bei der radiojodtherapie des differenzierten schilddru- senkarzinoms Laryngol Rhinol Otol (Stuttg) 67 1988 362
30. Delprat C.C. Hoefnagel C.A. Marcuse H.R. The influence of 131-1 therapy in thyroid cancer on the function of salivary glands Acta Endocrinologica 252 suppl 1983 73
31. Dewan S.S. Sharma S.M. Ganatra R.D. Radioiodine in treatment of metastatic thyroid cancer International I Nucl Med Biol 6 1979 213
32. Dobyns B.M. Maloof F. The study and treatment of 119 cases of carcinoma of the thyroid with radioactive iodine J Clin Endocrinol 11 1951 1323
33. Edmonds C.J. Hayes S. Kermode H. Measurement of serum TSH and thyroid hormones in the management and treatment of thyroid carcinoma with radioiodine Br I Radiol 50 1977 799
34. Edmonds C.J. Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine Br J Radiol 59 1986 45
35. Fernandez-Ulloa M. Maxon H.R. Mehta S. Iodine 131 uptake by primary lung adenocarcinoma: Misinterpretation of 131I scan JAMA 236 1976 857
36. Fogelman I. Maisey M.N. The thyroid scan in the management of thyroid disease Greeman L.M. Weissmann H.S. Nuclear Medicine Annual 1989 Raven Press New York 1
37. Gilmore J.R. The gross anatomy of the parathyroid glands J Pathol Bacteriol 46 1938 133
38. Ginsberg J. Pedersen J.D. Von Westarp C. Cervical cord compression due to extension of a papillary thyroid carcinoma Am J Med 82 1987 156
39. Glanzmann C.H. Horst W. Therapie des metastasierenden schilddrusenadenokarzinoms mit 131-Jod: Erfahrungen bei 103 patienten aus dem Zeitraum 1963 bis 1977 Strahlentherapie 155 1979 223
40. Glazebrook G.A. Effect of decicurie doses of radioactive iodine 131 on parathyroid function Am J Surg 154 1987 368
41. Goh K.O. Radioiodine treatment during pregnancy: Chromosomal aberrations and cretin ism associated with maternal iodine-131 treatment J Am Med Worn Assoc 36 1981 262
42. Goldman J.M. Line B.R. Aamodt R.L. Influence of triiodothyronine withdrawal time on 131-1 uptake postthyroidectomy for thyroid cancer J Clin Endocrinol Metab 50 1980 734
43. Goolden A.W.G. Mallard J.R. Farran H.E.A. Radiation sialitis following radioiodine therapy Br J Radiol 30 1957 210
44. Goslings B.M. Effect of a low iodine diet on 131-1 therapy in follicular thyroid carcinomata J Endocrinol 64 1975 30P
45. Green J.P. Wilcox J.R. Marriott J.D. Thyroid uptake of 131I: Further comparisons of capsules and liquid preparations J Nucl Med 17 1976 310
46. Greenler D.P. Klein H.A. The scope of false-positive iodine-131 images for thyroid carcinoma Clin Nucl Med 14 1989 111
47. Gunter H.H. Junker D. Schober O. Dosimetrie des hamatopoetischen systems bei der radiojodtherapie des schilddrusenkarzinoms Strahlentherapie und Onkologie 163 1987 185
48. Gunter H.H. Schober O. Schwarzrock R. Hamatologische langzeitveranderungen nach radiojodtherapie des schilddrusenkarzinoms Strahlentherapie und Onkologie 163 1987 475
49. Hadjieva T. Quantitative approach to radioiodine ablation of thyroid remnants following surgery for thyroid cancer Radiobiol Radiother 26 1985 819
50. Hainan K.E. The non-surgical treatment of thyroid cancer Br J Surg 62 1975 769
51. Hamburger J.I. Diuretic augmentation of 131I uptake in inoperable thyroid cancer N Engl J Med 280 1969 1091
52. Handelsman D.R. Conway A.J. Donnelly P.E. Azoospermia after iodine-131 treatment for thyroid carcinoma Br Med J 281 1980 1527
53. Handelsman D.J. Turtle J.R. Testicular damage after radioactive iodine (1-131) therapy for thyroid cancer Clin Endocrinol 18 1983 465
54. Haynie T.P. Beierwaltes W.H. Hematologic changes observed following 1-131 therapy for thyroid carcinoma J Nucl Med 4 1963 85
55. Hays M.T. Solomon D.H. Beall G.N. Suppression of human thyroid function by antibodies to bovine thyrotropin J Clin Endocrinol 27 1967 1540
56. Hermann M. Kober F. Keminger K. Die fernmetastasierung der struma maligna: Eine retrospektive Studie uber 892 falle Onkologie 10 1987 350
57. Hershman J.M. Edwards C.L. Serum thyrotropin (TSH) levels after thyroid ablation compared with TSH levels after exogenous bovine TSH: Implications for 131-1 treatment of thyroid carcinoma J Clin Endocrinol 34 1972 814
58. Hilts S.V. Heilman D. Anderson J. Serial TSH determination after T3 withdrawal or thyroidectomy in the therapy of thyroid carcinoma J Nucl Med 20 1979 928
59. Hoschl R. Choy D.H.L. Gandevia B. Iodine-131 uptake in inflammatory lung disease: A potential pitfall in treatment of thyroid carcinoma J Nucl Med 29 1988 701
60. Hurley J.R. Becker D.V. Treatment of thyroid carcinoma with radioiodine Gottschalk A. Hoffer P.B. Potchen E.J. Berger H.J. Diagnostic Nuclear Medicine 1988 Williams & Wilkins Second Edition. Baltimore 792
61. International Commission on Radiological Protection: Committee I: The evaluation of risks from radiation Health Physics 12 1966 239
62. Jackson G.L. Graham W.P. Flickinger F.W. Thymus accumulation of radioactive iodine Pennsylvania Med 82 1979 37
63. Jeevanram R.K. Shah D.H. Sharma S.M. Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients Nucl Med Biol 13 1986 277
64. Joensuu H. Klemi P.J. Paul R. Survival and prognostic factors in thyroid carcinoma Acta Radiologica Oncology 25 1986 243
65. Keldsen N. Mortensen B.T. Hansen H.S. Bone marrow depression due to 131I treatment of thyroid cancer Ugeskr Laeger 150 1988 2817
66. Kim E.E. Pjura G. Gobuty A. 131I uptake in a benign serous cystadenoma of the ovary Eur J Nucl Med 9 1984 433
67. Kimmig B. Hermann H.J. Measurement of dose during radioiodine treatment of thyroid cancer Acta Endocrinologica 252 suppl 1983 72
68. Koral K.F. Adler R.S. Carey J.E. Iodine-131 treatment of thyroid cancer: Absorbed dose calculated from post-therapy scans J Nucl Med 27 1986 1207
69. Krugman L.G. Hershman J.M. Chopra I.J. Patterns of recovery of the hypothalamic- pituitary-thyroid axis in patients taken off chronic thyroid therapy } Clin Endocrinol Metab 41 1975 70
70. Lakshmanan M. Reynolds J. Unexpected pelvic radioiodine uptake in a young woman after thyroidectomy for papillary carcinoma Endocrinology 120 1987 T 89
71. Lakshmanan M. Schaffer A. Robbins J. A simplified low iodine diet in 131I scanning and therapy of thyroid cancer Clin Nucl Med 13 1988 866
72. Lee C.M. Javitch J.A. Snyder S.H. Recognition sites for norepinephrine uptake: Regulation by neurotransmitter Science 220 1983 626
73. Lee T.C. Harbert J.C. Dejter S.W. Vocal cord paralysis following 131I ablation of a postthyroidectomy remnant J Nucl Med 26 1985 49
74. Leeper R. Controversies in the treatment of thyroid cancer: The New York Memorial Hospital approach Thyroid Today V 4 1982 l
75. Leeper R.D. Thyroid cancer Med Clin North Am 69 1985 1079
76. Leeper R.D. Shimaoka K. Treatment of metastatic thyroid cancer Clin Endocrinol Metab 9 1980 383
77. Levy H.A. Park C.H. Effect of reserpine on salivary gland radioiodine uptake in thyroid cancer Clin Nucl Med 12 1987 303
78. Maheshwari Y.K. Hill C.S. Jr. Haynie T.P. III 131I therapy in differentiated thyroid carcinoma: M.D Anderson Hospital experience. Cancer 47 1981 664
79. Maruca J. Santner S. Miller K. Prolonged iodine clearance with a depletion regimen for thyroid carcinoma: Concise communication J Nucl Med 25 1984 1089
80. Maslack M.M. Wilson C.A. 131Iodine accumulation in a pericardial effusion J Nucl Med 28 1987 133
81. Massin J.P. Savoie J.C. Gamier H. Pulmonary metastases in differentiated thyroid carcinoma: Study of 58 cases with implications for the primary tumor treatment Cancer 53 1984 982
82. Maxon HR, Thomas SR, Becker DV, et al: Induction of Thyroid Cancer by Ionizing Radiation. NCRP Report No. 80. Bethesda, National Council on Radiation Protection and Measurements, 1985, p 61
83. Maxon H.R. Thomas S.R. Boehringer A. Low iodine diet in 131I ablation of thyroid remnants Clin Nucl Med 8 1983 123
84. Maxon H.R. Thomas S.R. Hertzberg V.S. Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer N Engl J Med 309 1983 937
85. Maxon R. Thomas S.R. Maxon H. Effect of gut retention on the effective whole body half-time of iodine-131 in thyroid cancer patients J Nucl Med Technology 15 1987 13
86. Mazzaferri E.L. Papillary thyroid carcinoma: Factors influencing prognosis and current therapy Semin Oncol 14 1987 315
87. McConahey W.M. Hay I.D. Woolner L.B. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome Mayo Clin Proc 61 1986 978
88. McEwan A.C. Absorbed doses in the marrow during 131I therapy Br J Radiol 50 1977 329
89. Moore J.H. Bacharach B. Choi H.Y. Anaplastic transformation of metastatic follicular carcinoma of the thyroid J Surg One 29 1985 216
90. Muherji S. Zeissman H.A. Earll J.M. False positive iodine-131 whole body scan due to pectus excavatum Clin Nucl Med 13 1988 207
91. Nemee J. Rohling S. Zamrazil V. Comparison of the distribution of diagnostic and thyroablative 131I in the evaluation of differentiated thyroid cancers J Nucl Med 20 1979 92
92. Nemee J. Zamrazil V. Pohunkova D. Some factors influencing the survival of patients with less advanced stages of differentiated thyroid cancer Endocrinologia Experimentalis 20 1986 85
93. Norman J.A. Pickford C.J. Sanders T.W. Human intake of arsenic and iodine from seaweed-based food supplements and health foods available in the UK Food Additives and Contaminants 5 1987 103
94. Ozaki O. Ito K. Manabe Y. Clinical study on pulmonary metastases of differentiated thyroid carcinoma–with special reference to the extent of thyroid resection and RI therapy J Japanese Surg Society 86 1985 1596
95. Panza N. De Rosa M. Lombardi G. Pseudotumor cerebri and thyroid-replacement therapy in patients affected by differentiated thyroid carcinoma J Endocrinol Invest 8 1985 357
96. Park H.M. Tarver R.D. Schauweeker D.S. Spurious thyroid cancer metastasis: Saliva contamination artifact in high dose iodine-131 metastases survey J Nucl Med 27 1986 634
97. Park Y.K. Harland B.F. Vanderveen J.E. Estimation of dietary iodine intake of Americans in recent years J Am Dietetic Association 79 1981 17
98. Pochin E.E. Radioiodine therapy of thyroid cancer Semin Nucl Med 1 1971 503
99. Pons F. Carrio I. Estorch M. Lithium as an adjuvant of iodine-131 uptake when treating patients with well-differentiated thyroid carcinoma Clin Nucl Med 12 1987 644
100. Preisman R.A. Halpern S.E. Shishido R. Uptake of 131I by a papillary meningioma AJR 129 1977 349
101. Prunneil J.B. Duffy D.J. Godwin J.T. The distribution of radioactive iodine in human tissues: Necropsy study in nine patients J Clin Endocrinol 10 1950 1007
102. Rail J.E. Miller W.N. Foster C.G. The use of thiouracil in the treatment of metastatic carcinoma of the thyroid with radioiodine J Clin Endocrinol 11 1951 1273
103. Ramanna L. Waxman A.D. Brachman M.B. Treatment rationale in thyroid carcinoma: Effect of scan dose Clin Nucl Med 10 1985 687
104. Rigler R.G. Scanlon P.W. Radiation parotitis from radioactive iodine therapy Proc Staff Meetings Mayo Clin 30 1955 149
105. Robbins J. The role of TRH and lithium in the management of thyroid cancer Andreoli M. Monaco F. Robbins J. Advances in Thyroid Neoplasia 1981 Field Educational Italia Rome 233
106. Robertson J.S. Gorman C.A. Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism J Nucl Med 17 1976 826
107. Samaan N.A. Maheshwari Y.K. Nader S. Impact of therapy for differentiated carcinoma of the thyroid: An analysis of 706 cases J Clin Endocrinol Metab 56 1983 1131
108. Samaan N.A. Schultz P.N. Haynie T.P. Pulmonary metastasis of differentiated thyroid carcinoma: Treatment results in 101 patients J Clin Endocrinol Metab 60 1985 376
109. Sarkar S.D. Beierwaltes W.H. Gill S.P. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer J Nucl Med 17 1976 460
110. Schelfhout L.J.D.M. Creutzberg C.L. Hamming J.F. Multivariate analysis of survival in differentiated thyroid cancer: The prognostic significance of the age factor Eur J Cancer Clin Oncol 24 1988 331
111. Schlumberger M. Arcangioli O. Piekarski J.D. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest x-rays J Nucl Med 29 1988 1790
112. Schlumberger M. Tubiana M. de Vathaire F. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma J Clin Endocrinol Metab 63 1986 960
113. Schneyer L.H. Effect of administration of radioactive iodine on human salivary gland function J Dent Res 32 1953 146
114. Schober O. Gunter H.H. Schwarzrock R. Hamatologische langzeitveranderungen bei der radiojodtherapie des schilddrusenkarzinoms Strahlentherapie und Onkologie 163 1987 464
115. Schraube P. Kimmig B. zum Winkel K. Lithium als adjuvans in der radiojodtherapie des schilddrusenkarzinoms Nuklearmedizin 23 1984 151
116. Schull W.J. Otake M. Neel J.V. Genetic effects of the atomic bombs: A reappraisal Science 213 1981 1220
117. Simpson W.J. McKinney S.E. Carruthers J.S. Papillary and follicular thyroid cancer: Prognostic factors in 1578 patients Am J Med 83 1987 479
118. Simpson W.J. Panzarella T. Carruthers J.S. Papillary and follicular thyroid cancer: Impact of treatment in 1578 patients I J Radiation Oncology Biol Phys 14 1988 1063
119. Smith R. Blum C. Benua R.S. Radioactive iodine treatment of metastatic thyroid carcinoma with clinical thyrotoxicosis Clin Nucl Med 10 1985 874
120. Sorokin I.N. Parotid gland function following radioiodine therapy of thyroid cancer based on data from radionuclide sialoscintigraphy Stomatologiia Mosk 66 1987 50
121. Spiegel W, Reiners C, Börner W: Sialadenitis following iodine-131 therapy for thyroid carcinoma. J Nucl Med 26:816, 1985 (letter)
122. Thomas S.R. Maxon H.R. Fritz K.M. A comparison of methods for assessing patient body burden following 131I therapy for thyroid cancer Radiology 137 1980 839
123. Thomas S.R. Maxon H.R. Kereiakes J.G. In vivo quantitation of lesion radioactivity using external counting methods Med Phy 3 1976 253
124. Thomas S.R. Maxon H.R. Kereiakes J.G. Quantitative external counting techniques enabling improved diagnostic and therapeutic decisions in patients with well-differentiated thyroid cancer Radiology 122 1977 731
125. Torng J.K. Chen Y.C. Liu C.H. A case of chronic myelogenous leukemia following 131I therapy for metastatic thyroid carcinoma J Formosan Med Assoc 83 1984 730
126. Trujillo J. Krinsky S. Wilson B. Reducing radiation exposure during oral 131I therapy administration J Nucl Med Technology 10 1982 151
127. Tubiana M. Schlumberger M. Rougier P. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma Cancer 55 1985 794
128. Uayeh E.L. Meade R.C. Reutz P.P. Radionuclide study of struma ovarii J Nucl Med 14 1973 118
129. United Nations Scientific Committee on the Effects of Atomic Radiation: Ionizing Radiation: Levels and effects. A Report of the United Nations Scientific Committee on the Effects of Atomic Radiation to the General Assembly. New York, United Nations, 1972
130. Waxman A. Ramanna L. Chapman N. Significance of 131I scan dose in patients with thyroid cancer: Determination of ablation: Concise communication I Nucl Med 22 1981 861
131. Wu S.Y. Kollin J. Coodley E. 131I total body scan: Localization of disseminated gastric adenocarcinoma Case Report and Survey of the Literature. J Nucl Med 25 1984 1204
132. Young R.L. Mazzaferri E.L. Rahe A.J. Pure follicular thyroid carcinoma: Impact of therapy in 214 patients J Nucl Med 21 1980 733
133. Zimmerman D. Hay I.D. Gough I.R. Papillary thyroid carcinoma in children and adults: Long-term follow-up of 1039 patients conservatively treated at one institution during three decades Surgery 104 1988 1157